Pharmafile - Business Services News
The agreement was worth more than double the biotech's market value and serves to bolster Allergan's skincare pipeline.
Mylan's Heather Bresch is set to answer questions following the controversy of the company's price increases to its EpiPen
Shingrix showed a 90% efficacy in patients aged 70 and older that was retained over four years compared to MSD's Zostavax
European Commission approves the use of Eisai’s Kisplyx (lenvatinib) for the treatment of renal cell carcinoma
The agreement comes at the end of weeks and months of relentless negotiations.
German drugmaker brings in financial services firm JPMorgan Chase to help assess its options regarding the sale of its dermatology unit as it...
From CEO step-downs to baffling drug rejections, check out the most read stories on Pharmafile.com after another busy week in pharma with our top ten
Check out the latest news in the industry, plus special features on Brexit, cloud computing and trial transparency
Greenland Holdings, Ping An Trust, Agile Group and Poly Sino Capital joins forces to deliver a new San Fancisco-based R&D site
Lung cancer drug receives thumbs up despite earlier rejection